Avalo Therapeutics Stock Gains 38% Over Pricing Of $375 Mln Offering
Stock of Avalo Therapeutics, Inc. (AVTX) is rising about 38 percent in Wednesday morning trading after the company priced an offering of 250 million shares of common stock and pre-funded warrants at a combined price of $1.50 per share. This article is part of our premium content offering.Subscribe with a RTTNews subscription. The company's shares are currently trading at $22.42 on the Nasdaq, up 38.13 percent. The stock opened at $22.80 and has climbed as high as $23.71 so far in today's session. Over the p ...